STONKWHISPER
← Back to Intel
Insider ActivityCOGT

Fairmount Funds Management LLC, Director at Cogent Biosciences, Inc., sold $242.6M of COGT

Updated Jun 14, 2026
Fairmount Funds Management LLC Director
Cogent Biosciences, Inc. · $COGT
$242.6M Total Value
7,000,000 Shares Traded
$34.66 Price / Share
5,503,418 Shares Owned After
2026-03-31 Filing Date

Transaction Details

InsiderFairmount Funds Management LLC
TitleDirector
CompanyCogent Biosciences, Inc.
TickerCOGT
Transaction TypeSale
Transaction Date2026-03-31
Shares Traded7,000,000
Price Per Share$34.66
Total Value$242.6M
Filed Date2026-03-31
Accession Number0001104659-26-038057

Ownership Context

Shares Owned After Transaction5,503,418
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001104659-26-038057

Other Insider Trades — COGT

Other Trades by Fairmount Funds Management LLC

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for COGT — Cogent Biosciences, Inc. →

Track COGT insider activity in real time on The Wire →

Get alerts when Fairmount Funds Management LLC files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:20 UTC

Want real-time data? Access The Wire for live sentiment tracking.